FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Guardian Pharmacy Services, Inc. Stock AnalysisComprehensive stock analysis for Guardian Pharmacy Services, Inc. (GRDN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGRDN
GRDN
Guardian Pharmacy Services, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GRDN
Home🔹Stocks🔹Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.

🇺🇸GRDN•NYSE

Guardian Pharmacy Services, Inc.

🇺🇸GRDN•NYSE
Market cap
$2.76B
Sentiment

Your view on GRDN

Mkt Cap
$2.76B
Sentiment
Your view
GRDN
Guardian Pharmacy Services, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GRDN
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Guardian Pharmacy Services, Inc.

Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Fred Burke
Headquarters
US
Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Fred Burke
Headquarters
US
Description

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States.

Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Guardian Pharmacy Services, Inc., and the rating behind it. GRDN last traded at $43.64, 42.3× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Guardian Pharmacy Services, Inc.. Starting points for Guardian Pharmacy Services, Inc.: P/E 42.3, EPS $1.04, beta 0.10 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Guardian Pharmacy Services, Inc.. Guardian Pharmacy Services, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Guardian Pharmacy Services, Inc.. Trailing twelve-month EPS for Guardian Pharmacy Services, Inc. stands at $1.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Guardian Pharmacy Services, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Guardian Pharmacy Services, Inc. valued side by side against its closest peers. Guardian Pharmacy Services, Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Guardian Pharmacy Services, Inc., and how their positions are changing. At a $2.76B market value, institutional positions materially move Guardian Pharmacy Services, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Guardian Pharmacy Services, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Guardian Pharmacy Services, Inc.. Guardian Pharmacy Services, Inc. is a $2.76B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Guardian Pharmacy Services, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Guardian Pharmacy Services, Inc.. Coverage tracks Guardian Pharmacy Services, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • EWTX — Edgewise Therapeutics, Inc.
  • JANX — Janux Therapeutics, Inc.
  • MD — Pediatrix Medical Group, Inc.
  • MESO — Mesoblast Limited
  • NHC — National HealthCare Corporation
  • NUVB — Nuvation Bio Inc.
  • PRCT — PROCEPT BioRobotics Corporation
  • QDEL — QuidelOrtho Corporation

More Medical - Care Facilities companies

  • CRRX.TO — CareRx Corporation
  • CVSGF — CVS Group plc
  • CYH — Community Health Systems, Inc.
  • CYIO — CYIOS Corporation
  • DCGO — DocGo Inc.
  • DPAT — Dental Patient Care America, Inc.
  • DR.TO — Medical Facilities Corporation
  • DRWN — Quantum Medical Transport, Inc.
  • DVA — DaVita Inc.
  • EHC — Encompass Health Corporation
  • ENSG — The Ensign Group, Inc.
  • ERUC — ER Urgent Care Holdings, Inc.

ETFs holding Guardian Pharmacy Services, Inc.

  • SAWS — AAM Sawgrass US Small Cap Quality Growth ETF (3.28%)
  • XHS — State Street SPDR S&P Health Care Services ETF (1.69%)
  • PTH — Invesco Dorsey Wright Healthcare Momentum ETF (0.84%)
  • LITL — Simplify Piper Sandler US Small-Cap PLUS Income ETF (0.69%)
  • FYC — First Trust Small Cap Growth AlphaDEX Fund (0.58%)
  • FPX — First Trust US Equity Opportunities ETF (0.51%)
  • AIMS — Acuitas Small Cap Active ETF (0.43%)
  • DWAS — Invesco Dorsey Wright SmallCap Momentum ETF (0.41%)

News

Latest Market News